Registered Members Login:
   
Forgotten Your Details? Click Here To Recover +
Welcome To The ShareCafe Community - Talk Shares And Take Stock With Smart Investors - New Here? Click To Register >

4874 Pages (Click to Jump) V  « < 4831 4832 4833 4834 4835 4836 4837 > »    
 
  
Reply to this topic

CUV, CLINUVEL PHARMACEUTICALS LIMITED
stainless
post Posted: Jun 2 2004, 03:13 PM
  Quote Post


Posts: 103
Thanks: 2


Weekly and monthly charts still in clear uptrend, daily looks a little different, but its too early to call it a down trend. Stock was over bought in April so a retracement was always on the cards, good support at $0.80 will hold imho. You won't get them below this. There's too much positive news on the horizon. As for director selling down, well he's only sold 4.5% of his holding!!!! And has stated he's selling no more this year, hardly worth worrying about me thinks.

as I've said before - Patience Grasshoppers!

ps. the BBY report gave ept a potential value of $3.80 to $5.00!!!, so relax.

cheers, stainless

 
Californianpower
post Posted: Jun 2 2004, 03:02 PM
  Quote Post


Posts: 242
Thanks: 1


Watch the chart, its in a down trend......... and the chairman?? have a read of Buffets books, if you truley belive in the business you wouldnt be selling down the stock, that would especially apply to the chairman i think...

i guess its a matter of opinion

 
Krumbs
post Posted: Jun 2 2004, 02:53 PM
  Quote Post


Posts: 3,207
Thanks: 72


History. dated February 23, 2004

 
crowman28
post Posted: Jun 2 2004, 02:46 PM
  Quote Post


Posts: 6,627
Thanks: 13


I hope today's selloff is not due to the Huntley's report? I couldn't beleive they recommend a buy below 73 cents.

The report is quite negative about the chairman selling down his stake. But that's life!

 
stolwyk
post Posted: Jun 2 2004, 02:10 PM
  Quote Post


Posts: 73


Huntley's report:

http://www.epitan.com.au/irm/Company/ShowPage.aspx?CPID=969

 
Quinent
post Posted: Jun 1 2004, 04:13 PM
  Quote Post


Posts: 147
Thanks: 2


mongoose,

Thanks for that... more good news for EPT then...

Cheers,

Brendan

 

sentifi.com

Share Cafe Sentifi Top themes and market attention on:


mongoose
post Posted: Jun 1 2004, 03:45 PM
  Quote Post


Posts: 369
Thanks: 19


yes see anouncement attached
Attached File(s)
Attached File  psd.pdf ( 89.25K ) Number of downloads: 564

 


 
Quinent
post Posted: Jun 1 2004, 03:31 PM
  Quote Post


Posts: 147
Thanks: 2


Aren't EPT in bed somehow with PSD ? If so, then this might be helpful for EPT...


From the Sydney Morning Herald...

Nanotechnology firm pSivida Ltd's United Kingdom subsidiary has been granted a patent for a type of silicon implant in the European market.

The patent, granted to pSiMedica Ltd, provides protection for silicon implants comprising tissue-compatible biodegradable silicon for drug delivery.

The European patent follows six earlier patent grants in the key jurisdictions of Europe and the United States.

PSivida shares were two cents higher at $1.28 in morning trade on Tuesday.



 
Quinent
post Posted: Jun 1 2004, 02:38 PM
  Quote Post


Posts: 147
Thanks: 2


crassus,

I think the $30 million figure is to get the drug through Phase III trials.. ie ready for the market... to actually take it to market would cost considerably more I think... ie production, distribution, marketing, etc....

I think we would all be happy if they got some upfront payments along with $50 million a year in sales revenue...

Cheers,

Brendan

 
crassus
post Posted: Jun 1 2004, 11:36 AM
  Quote Post


Posts: 705


This amendment is better isnt it? now they think EPT will make MORE than US$50million/yr, thats if it partners with a major pharma, and gets 5-10%

If it takes melantan to market itself, which would cost about $30million, it would get 100% of sales.



 
 


4874 Pages (Click to Jump) V  « < 4831 4832 4833 4834 4835 4836 4837 > » 

Back To Top Of Page
Reply to this topic


You agree through the use of ShareCafe, that you understand and accept the TERMS OF USE.


TERMS OF USE  -  CONTACT ADMIN  -  ADVERTISING